KR950701227A - 사이클로스포린 유도체를 포함하는 약학 조성물(pharmaceutical composition containing cyclosporin derivative) - Google Patents

사이클로스포린 유도체를 포함하는 약학 조성물(pharmaceutical composition containing cyclosporin derivative)

Info

Publication number
KR950701227A
KR950701227A KR1019940703729A KR19940703729A KR950701227A KR 950701227 A KR950701227 A KR 950701227A KR 1019940703729 A KR1019940703729 A KR 1019940703729A KR 19940703729 A KR19940703729 A KR 19940703729A KR 950701227 A KR950701227 A KR 950701227A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
composition containing
containing cyclosporin
cyclosporin derivative
composition
Prior art date
Application number
KR1019940703729A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950701227A publication Critical patent/KR950701227A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
KR1019940703729A 1992-04-22 1994-10-20 사이클로스포린 유도체를 포함하는 약학 조성물(pharmaceutical composition containing cyclosporin derivative) KR950701227A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929208712A GB9208712D0 (en) 1992-04-22 1992-04-22 Pharmaceutical compositions containing cyclosporin derivates
PCT/EP1993/000955 WO1993020833A1 (en) 1992-04-22 1993-04-20 Pharmaceutical composition containing cyclosporin derivative

Publications (1)

Publication Number Publication Date
KR950701227A true KR950701227A (ko) 1995-03-23

Family

ID=10714386

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019940703729A KR950701227A (ko) 1992-04-22 1994-10-20 사이클로스포린 유도체를 포함하는 약학 조성물(pharmaceutical composition containing cyclosporin derivative)
KR10-2000-7013956A KR100414853B1 (ko) 1992-04-22 2000-12-08

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR10-2000-7013956A KR100414853B1 (ko) 1992-04-22 2000-12-08

Country Status (22)

Country Link
EP (1) EP0637248B1 (ko)
JP (1) JP2818298B2 (ko)
KR (2) KR950701227A (ko)
AT (1) ATE219940T1 (ko)
AU (1) AU672793B2 (ko)
CA (1) CA2132740C (ko)
CY (1) CY2399B1 (ko)
CZ (1) CZ287359B6 (ko)
DE (1) DE69332078T2 (ko)
DK (1) DK0637248T3 (ko)
ES (1) ES2179052T3 (ko)
FI (1) FI111130B (ko)
GB (1) GB9208712D0 (ko)
HU (1) HU218279B (ko)
NO (1) NO315075B1 (ko)
NZ (1) NZ252681A (ko)
PT (1) PT637248E (ko)
RU (1) RU2126263C1 (ko)
SG (1) SG50692A1 (ko)
SK (1) SK282745B6 (ko)
UA (1) UA34454C2 (ko)
WO (1) WO1993020833A1 (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
JP3631490B2 (ja) 1992-05-13 2005-03-23 ノバルティス ファーマ株式会社 シクロスポリン含有眼科用組成物
DK0589843T3 (da) * 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
GB2315216B (en) * 1993-10-05 1998-10-14 Ciba Geigy Ag Microemulsion preconcentrates comprising FK506 or 33-epi-chloro-33-desoxy-ascomycin
HUT77283A (hu) 1994-11-03 1998-03-30 Novartis Ag. Egyszerű összetételű, a hatóanyagot biológiailag jól hozzáférhetően tartalmazó, orális alkalmazásra szánt új ciklosporinkészítmény és eljárás az előállítására
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
DK0989851T3 (da) * 1997-07-29 2003-01-27 Upjohn Co Selvemulgerende formulering indeholdende sure lipofile forbindelser
CA2294031E (en) * 1997-07-29 2012-04-03 Pharmacia & Upjohn Company Self-emulsifying formulation for lipophilic compounds
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
CZ20033341A3 (cs) 2001-06-21 2004-10-13 Pfizeráproductsáinc Samoemulgující se kompozice inhibitorů přenosového proteinu cholesterylesteru
US6828301B2 (en) 2002-02-07 2004-12-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for hepatitis C viral protease inhibitors
EP2204167A1 (en) 2009-01-05 2010-07-07 Azad Pharma AG Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules
MA33491B1 (fr) 2009-07-07 2012-08-01 Boehringer Ingelheim Int Composition pharmaceutique pour un inhibiteur de protease virale de l'hépatite c

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
ATE95193T1 (de) * 1987-06-17 1993-10-15 Sandoz Ag Cyclosporine und deren benutzung als arzneimittel.
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins

Also Published As

Publication number Publication date
EP0637248B1 (en) 2002-07-03
AU672793B2 (en) 1996-10-17
ATE219940T1 (de) 2002-07-15
NZ252681A (en) 1996-02-27
UA34454C2 (uk) 2001-03-15
DK0637248T3 (da) 2002-10-28
RU94046413A (ru) 1996-11-10
HU9403055D0 (en) 1994-12-28
NO315075B1 (no) 2003-07-07
NO943998D0 (no) 1994-10-21
CY2399B1 (en) 2004-09-10
SK127294A3 (en) 1995-04-12
SK282745B6 (sk) 2002-12-03
ES2179052T3 (es) 2003-01-16
DE69332078T2 (de) 2002-12-19
HUT71580A (en) 1995-12-28
KR100414853B1 (ko) 2004-01-13
PT637248E (pt) 2002-11-29
JPH07505872A (ja) 1995-06-29
EP0637248A1 (en) 1995-02-08
CA2132740C (en) 2008-01-15
FI111130B (fi) 2003-06-13
CZ287359B6 (en) 2000-11-15
WO1993020833A1 (en) 1993-10-28
HU218279B (en) 2000-07-28
CZ261794A3 (en) 1995-02-15
NO943998L (no) 1994-10-21
JP2818298B2 (ja) 1998-10-30
AU4261193A (en) 1993-11-18
DE69332078D1 (de) 2002-08-08
RU2126263C1 (ru) 1999-02-20
SG50692A1 (en) 1999-05-25
FI944978A (fi) 1994-10-21
FI944978A0 (fi) 1994-10-21
GB9208712D0 (en) 1992-06-10
CA2132740A1 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
KR950701227A (ko) 사이클로스포린 유도체를 포함하는 약학 조성물(pharmaceutical composition containing cyclosporin derivative)
TNSN92004A1 (fr) Derive de la 5h-pyrrolo (3,4-b) pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent
MX9204379A (es) Microemulsiones de agua en aceite auto-emulsificables, estables, farmaceuticamente aceptables.
ATE201980T1 (de) Präparate mit lipophilen trägerstoffen
IT1272992B (it) Formulazioni galeniche contenenti macrolidi.
AU629669B2 (en) Diarylacetylenes, the preparations and use thereof
CA2178632A1 (en) Pharmaceutical compositions containing hiv protease inhibitors
EP0573423A4 (en) Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof
DE69700317T2 (de) Mikrotröpfchen-Arzneizubereitungen enthaltend Propofol
MX9204382A (es) Composiciones
MXPA97007996A (es) Preparado para el transporte de sustancias activas a traves de barreras.
KR950007857A (ko) 경구투여용 라파마이신 제제
NO175826C (no) Mikrobiologisk fremgangsmåte ved fremstilling av agrarkjemisk anvendelige virkestoffer, fremstilte forbindelser, anvendelsen av disse og biologisk rene kulturer av sorangium cellulosum som anvendes i fremgangsmåten
DE59205998D1 (de) Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung
KR890015674A (ko) 수면 시용 농약 입제
CO5640115A2 (es) 3,4-dihidropirido [1,2-a] pirimidinas sustituidas
AU8079891A (en) Bile alcohol and drug containing the same as active ingredient
MX9101804A (es) Composicion para preparaciones farmaceuticas solidas con vitaminas de activas y procedimiento para la preparacion de las mismas
IT8921516A0 (it) Procedimento di microincapsulazione di microorganismi vivi e composizioni farmaceutiche stabili.
IT8821313V0 (it) Dispositivo di bloccaggio per rotelle di poltrone scrivanie e simili.
FR2655344B1 (fr) Derives heterocycliques d'acylaminothiazoles, leur preparation et compositions pharmaceutiques en contenant.

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
J201 Request for trial against refusal decision
A107 Divisional application of patent
AMND Amendment
B701 Decision to grant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20090525

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee